• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[卵巢癌与手术刀。晚期卵巢癌]

[Ovarian cancer and the surgical knife. Advanced ovarian cancer].

作者信息

Bösze P

机构信息

Országos Onkológiai Intézet, Budapest, Nögyógyászati Onkológiai Osztály.

出版信息

Orv Hetil. 1993 Oct 10;134(41):2243-8.

PMID:8414467
Abstract

Surgery of advanced ovarian carcinoma includes total abdominal hysterectomy, bilateral salpingo-oophorectomy, partial or total omental resection and removal as much secondaries as possible. Distinction between optimal and suboptimal debulking is important in terms of survival. This is based on the size of the diameter of the largest residual tumour following primary surgery (< 2 cm vs > 2 cm). The value of lymphadenectomy is still controversial. However, it should be explored in prospective studies. The role of second-look laparotomy in advanced ovarian carcinoma remains debatable. Secondary debulking appears to be beneficial only if it is followed by adjunctive chemotherapy.

摘要

晚期卵巢癌的手术包括全腹子宫切除术、双侧输卵管卵巢切除术、部分或全部大网膜切除术以及尽可能多地切除转移灶。就生存率而言,区分最佳减瘤和次优减瘤很重要。这是基于初次手术后最大残留肿瘤直径的大小(<2厘米与>2厘米)。淋巴结切除术的价值仍存在争议。然而,应在前瞻性研究中进行探索。二次探查剖腹术在晚期卵巢癌中的作用仍有争议。只有在辅助化疗之后进行二次减瘤似乎才有益。

相似文献

1
[Ovarian cancer and the surgical knife. Advanced ovarian cancer].[卵巢癌与手术刀。晚期卵巢癌]
Orv Hetil. 1993 Oct 10;134(41):2243-8.
2
[Surgery in ovarian carcinoma].[卵巢癌手术]
Gan To Kagaku Ryoho. 1995 Aug;22(9):1176-81.
3
[Primary cytoreductive surgery of advanced ovarian cancer with special reference to the significance of bowel resection].[晚期卵巢癌的初次肿瘤细胞减灭术,特别提及肠切除的意义]
Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):1070-7.
4
Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma.
Zhonghua Yi Xue Za Zhi (Taipei). 2000 Mar;63(3):220-5.
5
Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer.
Gynecol Oncol. 1997 Jan;64(1):13-7. doi: 10.1006/gyno.1996.4540.
6
[The value of surgical staging in the early stages of ovarian carcinoma].
Wien Klin Wochenschr. 1990 Aug 3;102(15):437-40.
7
Advances in treatment of epithelial ovarian cancer.上皮性卵巢癌的治疗进展
Nagoya J Med Sci. 2006 Jan;68(1-2):19-26.
8
Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.晚期卵巢癌患者二次剖腹探查术中的手术细胞减灭术。
Anticancer Res. 2000 May-Jun;20(3B):1959-64.
9
Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.晚期卵巢癌二次剖腹探查术中的二次细胞减灭术:一项妇科肿瘤学组研究
Gynecol Oncol. 1997 Aug;66(2):171-8. doi: 10.1006/gyno.1997.4806.
10
Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.晚期卵巢癌的新辅助化疗或初次肿瘤细胞减灭术:285例患者的回顾性分析
Gynecol Oncol. 1998 Dec;71(3):431-6. doi: 10.1006/gyno.1998.5213.